Jun Yu

3.9k total citations
139 papers, 3.0k citations indexed

About

Jun Yu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jun Yu has authored 139 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 53 papers in Oncology and 26 papers in Organic Chemistry. Recurrent topics in Jun Yu's work include Metal complexes synthesis and properties (30 papers), Ferrocene Chemistry and Applications (20 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Jun Yu is often cited by papers focused on Metal complexes synthesis and properties (30 papers), Ferrocene Chemistry and Applications (20 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Jun Yu collaborates with scholars based in China, Australia and United States. Jun Yu's co-authors include Philip Beale, Fazlul Huq, Fazlul Huq, Yi Wang, Yongjian Xu, Weining Xiong, Qiurong Ruan, Ling Feng, Xiaotang Wang and Hong-Yan Gu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jun Yu

135 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Yu China 32 1.2k 625 442 391 375 139 3.0k
Soon‐Sun Hong South Korea 35 1.8k 1.5× 652 1.0× 537 1.2× 365 0.9× 223 0.6× 120 3.6k
Kyung Hee Jung South Korea 35 1.5k 1.3× 584 0.9× 343 0.8× 282 0.7× 198 0.5× 125 3.5k
Surajit Pathak India 32 1.7k 1.4× 781 1.2× 800 1.8× 218 0.6× 197 0.5× 177 4.0k
Heather Hatcher United States 18 1.5k 1.3× 407 0.7× 302 0.7× 178 0.5× 345 0.9× 23 3.9k
S. Asha Nair India 34 2.0k 1.7× 891 1.4× 592 1.3× 240 0.6× 286 0.8× 80 3.8k
Sumitra Miriyala United States 36 2.0k 1.7× 471 0.8× 608 1.4× 166 0.4× 428 1.1× 91 4.1k
Mateusz Kciuk Poland 19 1.3k 1.1× 671 1.1× 378 0.9× 318 0.8× 263 0.7× 51 2.7k
Srigiridhar Kotamraju India 37 2.4k 2.0× 686 1.1× 524 1.2× 686 1.8× 327 0.9× 82 5.3k
Hongyu Li China 35 2.2k 1.9× 605 1.0× 368 0.8× 1.0k 2.7× 216 0.6× 193 4.4k
Huanjie Yang China 32 2.0k 1.8× 721 1.2× 505 1.1× 281 0.7× 238 0.6× 57 3.8k

Countries citing papers authored by Jun Yu

Since Specialization
Citations

This map shows the geographic impact of Jun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yu more than expected).

Fields of papers citing papers by Jun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yu. The network helps show where Jun Yu may publish in the future.

Co-authorship network of co-authors of Jun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Yu. A scholar is included among the top collaborators of Jun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Yu. Jun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Peter, et al.. (2025). Precision oncology informatics for anticancer drug combination responses: A systematic review. Computers in Biology and Medicine. 196(Pt C). 110788–110788.
2.
Xu, Weilin, Jun Yan, Zachary D. Travis, et al.. (2025). Apelin/APJ system: a novel promising target for anti-oxidative stress in stroke. Frontiers in Pharmacology. 15. 1352927–1352927. 2 indexed citations
3.
Wang, Qi, Kai Wang, Qing Zhou, et al.. (2024). Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk. International Journal of Nanomedicine. Volume 19. 1827–1842. 7 indexed citations
4.
Zhang, Lei, Siyuan Wang, Guorao Wu, et al.. (2023). MBD2 facilitates tumor metastasis by mitigating DDB2 expression. Cell Death and Disease. 14(5). 303–303. 4 indexed citations
5.
Hu, Yinan, Qi Wang, Jun Yu, et al.. (2022). Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling. Nature Communications. 13(1). 41 indexed citations
6.
Feng, Xiaoning, et al.. (2022). MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7. International Journal of Medical Sciences. 19(2). 257–266. 33 indexed citations
7.
Liu, Peng, Kang Miao, Lei Zhang, et al.. (2020). Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation. Respiratory Research. 21(1). 58–58. 67 indexed citations
8.
Chen, Xueying, Qi Wang, Yinan Hu, et al.. (2020). <p>A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients</p>. International Journal of COPD. Volume 15. 379–388. 8 indexed citations
9.
10.
Xu, Yuzhu, et al.. (2017). GLCCI1 rs37973. Medicine. 96(52). e9442–e9442. 11 indexed citations
11.
Beale, Philip, Charles Chan, Jun Yu, et al.. (2016). Changes in the in vitro activity of platinum drugs when administered in two aliquots. BMC Cancer. 16(1). 688–688. 6 indexed citations
12.
Beale, Philip, et al.. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models. Journal of Ovarian Research. 6(1). 78–78. 21 indexed citations
13.
Yu, Jun, Yan Ma, Jeanne Drisko, & Qi Chen. (2013). Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Current Therapeutic Research. 75. 8–14. 44 indexed citations
14.
Beale, Philip, et al.. (2012). Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.. PubMed. 32(11). 4843–50. 38 indexed citations
15.
Li, Yan, Jun Yu, Mincai Li, Zhiling Qu, & Qiurong Ruan. (2010). Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells. Life Sciences. 88(3-4). 130–140. 12 indexed citations
17.
Xu, Mei, et al.. (2009). [Effect of silencing myocardin gene expression on differentiation of mouse bone mesenchymal stem cells into smooth muscle-like cells induced by PDGF-BB].. PubMed. 38(2). 117–20. 1 indexed citations
18.
Yu, Jun & Qiurong Ruan. (2007). [Filtrating smooth muscle progenitor cells from mouse bone marrow mesenchymal stem cells by recombinant Psm22alpha-EGFP-1].. PubMed. 36(12). 825–31. 1 indexed citations
19.
Yu, Jun, et al.. (2007). Crystallization and electrical properties of (Ba0.4Pb0.3)Sr0.3TiO3 thin film by pulsed laser deposition. Journal of Wuhan University of Technology-Mater Sci Ed. 22(4). 634–637. 2 indexed citations
20.
Liu, Feng, Tian‐Ling Ren, Yang Chen, Litian Liu, & Jun Yu. (2007). Magnetic properties of NiCuZn ferrite thin films prepared by the sol-gel method. Journal of Wuhan University of Technology-Mater Sci Ed. 22(3). 506–509. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026